Prevention and Preemptive Therapy of Posttransplant Lymphoproliferative Disease in Pediatric Liver Recipients1

SV McDiarmid, S Jordan, GS Lee, M Toyoda… - …, 1998 - journals.lww.com
Background. We have previously reported a 10% incidence of posttransplant
lymphoproliferative disease (PTLD) in pediatric patients receiving first liver grafts and …

Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice

N Kamiyama, R Soma, S Hidano, K Watanabe… - Antiviral research, 2017 - Elsevier
Zika fever, a mosquito-borne infectious disease caused by Zika virus (ZIKV), is an epidemic
disease for which no effective therapy has been established. The recent outbreaks of ZIKV in …

Recent advances in varicella-zoster virus infection

JI Cohen, PA Brunell, SE Straus… - Annals of internal …, 1999 - acpjournals.org
Varicella-zoster virus has developed a complex strategy that allows it to remain latent in the
body and avoid destruction by the immune system. Although varicella and zoster have been …

Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses

T Efferth, M Marschall, X Wang, SM Huong… - Journal of molecular …, 2002 - Springer
Antiviral therapy of primary and recurrent infections with human cytomegalovirus is reserved
for severe manifestations and faces several limitations. Presently candidates for novel drugs …

The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta-analysis

JL Jackson, R Gibbons, G Meyer… - Archives of Internal …, 1997 - jamanetwork.com
Background: Herpes zoster is a common affliction in older patients, with up to 15%
experiencing some residual pain in the distribution of the rash several months after healing …

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

SA Spector, R Wong, K Hsia, M Pilcher… - The Journal of …, 1998 - Am Soc Clin Investig
In this study, baseline plasma from 619 persons with acquired immunodeficiency syndrome
(AIDS)(median CD4+ lymphocyte count-21/microl) who participated in a trial to determine …

Repurposing of antimicrobial agents for cancer therapy: what do we know?

C Pfab, L Schnobrich, S Eldnasoury, A Gessner… - Cancers, 2021 - mdpi.com
Simple Summary Despite the leaps and bounds in the prevention and treatment of cancer, it
remains the second leading cause of death worldwide. A significant hurdle during cancer …

Recent advances in the prevention and treatment of congenital cytomegalovirus infections

SP Adler, G Nigro, L Pereira - Seminars in perinatology, 2007 - Elsevier
Continued but slow progress has led to recent advances in our understanding that
congenital cytomegalovirus (CMV) infection has occurred. We understand that the most …

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy

VC Emery, PD Griffiths - Proceedings of the National …, 2000 - National Acad Sciences
Cytomegalovirus (CMV) replicates rapidly in its human host with a doubling time of≈ 1 day.
Using simple mathematical models we show that the efficacy of the anti-CMV drug …

Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation

DG Wolf, CT Courcelle, MN Prichard… - Proceedings of the …, 2001 - National Acad Sciences
The human cytomegalovirus UL97 kinase, an important target of antiviral therapy, has an
impact on at least two distinct phases of viral replication. Compared with wild-type virus, the …